Skip to main content

Table 1 Prevalence of human papillomavirus (HPV) types by cytological findings and overall, among 2508 women. Rwanda, 2013–2014

From: Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme

HPV type

Normal (N = 2136)

ASCUS/ASC-H/LSIL (n = 210)

HSIL (n = 45)

Total (n = 2508) a

 

N

%

N

%

N

%

N

%

Negative

1510

70.7

56

26.7

2

4.4

1651

65.8

Positive

626

29.3

154

73.3

43

95.6

857

34.2

Multiple

250

11.7

85

40.5

23

51.1

377

15.0

High-risk

        

 16

88

4.1

23

11.0

13

28.9

131

5.2

 18

31

1.5

13

6.2

6

13.3

52

2.1

 31

35

1.6

12

5.7

4

8.9

54

2.2

 33

29

1.4

4

1.9

3

6.7

36

1.4

 35

48

2.2

20

9.5

4

8.9

75

3.0

 39

22

1.0

10

4.8

2

4.4

37

1.5

 45

36

1.7

12

5.7

4

8.9

55

2.2

 51

29

1.4

14

6.7

2

4.4

47

1.9

 52

50

2.3

20

9.5

3

6.7

76

3.0

 56

38

1.8

13

6.2

4

8.9

59

2.4

 58

38

1.8

17

8.1

9

20.0

68

2.7

 59

28

1.3

6

2.9

0

0.0

36

1.4

 68

11

0.5

2

1.0

2

4.4

16

0.6

 Any

378

17.7

113

53.8

40

88.9

557

22.2

Possibly high-risk

        

 26

9

0.4

4

1.9

3

6.7

16

0.6

 30

11

0.5

6

2.9

1

2.2

18

0.7

 34

0

0.0

1

0.5

0

0.0

1

0.0

 53

13

0.6

11

5.2

2

4.4

26

1.0

 66

39

1.8

18

8.6

1

2.2

63

2.5

 67

53

2.5

8

3.8

5

11.1

68

2.7

 69

11

0.5

5

2.4

0

0.0

17

0.7

 70

30

1.4

8

3.8

0

0.0

38

1.5

 73

13

0.6

2

1.0

1

2.2

19

0.8

 82

11

0.5

6

2.9

0

0.0

18

0.7

 85

4

0.2

1

0.5

1

2.2

6

0.2

 Any

167

7.8

60

28.6

10

22.2

248

9.9

Low risk

        

 6

28

1.3

10

4.8

0

0.0

40

1.6

 11

15

0.7

4

1.9

0

0.0

20

0.8

 Any

282

13.2

59

28.1

10

22.2

368

14.7

  1. aIncluding 117 women with missing/inadequate cytology